Lexaria Bioscience Corp. (LEXX)
0.70
+0.02
(+3.12%)
USD |
NASDAQ |
Mar 13, 16:00
0.70
0.00 (0.00%)
After-Hours: 20:00
Lexaria Bioscience EPS Diluted (Quarterly) : -0.0746 for Nov. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Oncolytics Biotech, Inc. | -0.1032 |
| Aurinia Pharmaceuticals, Inc. | 1.526 |
| Edesa Biotech, Inc. | -0.2819 |
| Xenon Pharmaceuticals, Inc. | -1.314 |
| ProMIS Neurosciences, Inc. | -5.928 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -1.598M |
| Total Expenses (Quarterly) | 1.595M |
| Enterprise Value | 12.71M |
| Earnings Yield | -82.06% |
| Normalized Earnings Yield | -80.79 |